AxioMed Spine Corporation, a Garfield Heights, Ohio-based spinal orthopedics company, has raised $5m in Series D financing.
The funding, which augments the previously announced $15m Series D round, was provided by current and new investors.
Led by CEO Patrick McBrayer and founder and COO James Kuras, the company focuses on the development of products designed to restore spinal function in patients with degenerative spine disease. Its Freedom® Lumbar Disc (FLD) is currently on the market in the EU and advancing toward completion of its Investigational Device Exemption (IDE) pivotal study in the US. AxioMed intends to follow a similar regulatory and marketing pathway as the FLD with its Freedom® Cervical Disc, which recently received a CE Mark for introduction in the EU.